Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

Blood (2024) 144 (8): 873–887.

https://doi.org/10.1182/blood.2024024499

Published: 2024

Includes: Supplemental data

Journal Articles

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination

Lisa Blixt, Yu Gao, David Wullimann, Hanna Murén Ingelman-Sundberg, Sandra Muschiol, Katie Healy, Gordana Bogdanovic, Elisa Pin, Peter Nilsson, Christian Kjellander, Alba Grifoni, Alessandro Sette, Margaret Sällberg Chen, Hans-Gustaf Ljunggren, Marcus Buggert, Lotta Hansson, Anders Österborg

Blood (2022) 140 (22): 2403–2407.

https://doi.org/10.1182/blood.2022016815

Published: 2022

Includes: Supplemental data

Journal Articles

CD38 Down-Regulation on Ex Vivo Activated and Expanded NK Cells for Cell Therapy Persists after Infusion

Hareth Nahi, Michael Chrobook, Stephan Meinke, Charlotte Gran, Nicole Marquardt, Gabriel Afram, Tolga Sutlu, Mari Gilljam, Birgitta Stellan, Arnika Kathleen Wagner, Lilian Walther-Jallow, Johan Liwing, Monika Klimkowska, Goesta Gahrton, Per Ljungman, Hans-Gustaf Ljunggren, Evren Alici

Blood (2021) 138 (Supplement 1): 4796.

https://doi.org/10.1182/blood-2021-152522

Published: 2021

Journal Articles

Efficient Scale-up and Pre-Clinical Evaluation of NKG2C+ Adaptive NK Cell Expansion for Therapy Against High-Risk AML/MDS

Blood (2018) 132 (Supplement 1): 195.

https://doi.org/10.1182/blood-2018-195

Published: 2018

Journal Articles

Complete Remission and Signs of Immunoediting Following Haploidentical NK Cell Therapy in Refractory High-Risk MDS and AML Ell Therapy in Refractory High-Risk MDS and AML

Andreas T Björklund, MD PhD MSc, Mattias Carlsten, MD PhD, Ebba Sohlberg, PhD, Trevor Clancy, Lisa Liu, Mohsen Karimi, PhD, Sarah Cooley, MD, Jeffrey S. Miller, MD, Emma Watz, Björn Engelbrekt Wahlin, Marzia Palma, MD PhD, Lotta Hansson, Per Ljungman, Eva Hellstrom-Lindberg, MD PhD, Hans-Gustaf Ljunggren, Karl-Johan Malmberg, MD PhD

Blood (2017) 130 (Supplement 1): 4458.

https://doi.org/10.1182/blood.V130.Suppl_1.4458.4458

Published: 2017

Journal Articles

Early and Transient Microchimerism Associated with Complete Remission after Adoptively Transferred Haploidentical NK Cells Against High Risk Myelodysplastic Syndrome and Refractory Acute Myeloid Leukemia

Andreas T Björklund, MDPhD, Mattias Carlsten, MD PhD, Marie Schaffer, PhD, Lisa Liu, MD, Sarah A. Cooley, MD MS, Jeffrey S. Miller, MD, Emma Watz, MD, Marzia Palma, MD PhD, Lotta Hansson, MD PhD, Björn E Wahlin, MD PhD, Lars Möllgård, MDPhD, Hans Hagglund, MD PhD, Pontus Blomberg, PhD, Per T. Ljungman, MD PhD, Eva Hellström-Lindberg, MD PhD, Hans-Gustaf Ljunggren, MD PhD, Karl-Johan Malmberg, MD, PhD

Blood (2014) 124 (21): 1120.

https://doi.org/10.1182/blood.V124.21.1120.1120

Published: 2014

Journal Articles

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs

Vivien Béziat, Lisa L. Liu, Jenny-Ann Malmberg, Martin A. Ivarsson, Ebba Sohlberg, Andreas T. Björklund, Christelle Retière, Eva Sverremark-Ekström, James Traherne, Per Ljungman, Marie Schaffer, David A. Price, John Trowsdale, Jakob Michaëlsson, Hans-Gustaf Ljunggren, Karl-Johan Malmberg

Blood (2013) 121 (14): 2678–2688.

https://doi.org/10.1182/blood-2012-10-459545

Published: 2013

Includes: Supplemental data

Journal Articles

Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production

Blood (2013) 121 (8): 1345–1356.

https://doi.org/10.1182/blood-2012-07-442558

Published: 2013

Includes: Supplemental data

Journal Articles

CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells

Niklas K. Björkström, Vivien Béziat, Frank Cichocki, Lisa L. Liu, Jeffrey Levine, Stella Larsson, Richard A. Koup, Stephen K. Anderson, Hans-Gustaf Ljunggren, Karl-Johan Malmberg

Blood (2012) 120 (17): 3455–3465.

https://doi.org/10.1182/blood-2012-03-416867

Published: 2012

Includes: Supplemental data

Journal Articles

Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D

Blood (2011) 118 (22): 5783–5793.

https://doi.org/10.1182/blood-2011-07-369090

Published: 2011

Includes: Supplemental data

Journal Articles

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56 dim NK-cell differentiation uncoupled from NK-cell education

Niklas K. Björkström, Peggy Riese, Frank Heuts, Sandra Andersson, Cyril Fauriat, Martin A. Ivarsson, Andreas T. Björklund, Malin Flodström-Tullberg, Jakob Michaëlsson, Martin E. Rottenberg, Carlos A. Guzmán, Hans-Gustaf Ljunggren, Karl-Johan Malmberg

Blood (2010) 116 (19): 3853–3864.

https://doi.org/10.1182/blood-2010-04-281675

Published: 2010

Includes: Supplemental data

Journal Articles

NK cells expressing inhibitory KIR for non–self-ligands remain tolerant in HLA-matched sibling stem cell transplantation

Andreas T. Björklund, Marie Schaffer, Cyril Fauriat, Olle Ringdén, Mats Remberger, Christina Hammarstedt, A. John Barrett, Per Ljungman, Hans-Gustaf Ljunggren, Karl-Johan Malmberg

Blood (2010) 115 (13): 2686–2694.

https://doi.org/10.1182/blood-2009-07-229740

Published: 2010

Journal Articles

Regulation of human NK-cell cytokine and chemokine production by target cell recognition

Cyril Fauriat, Eric O. Long, Hans-Gustaf Ljunggren, Yenan T. Bryceson

Blood (2010) 115 (11): 2167–2176.

https://doi.org/10.1182/blood-2009-08-238469

Published: 2010

Includes: Supplemental data

Journal Articles

Education of human natural killer cells by activating killer cell immunoglobulin-like receptors

Cyril Fauriat, Martin A. Ivarsson, Hans-Gustaf Ljunggren, Karl-Johan Malmberg, Jakob Michaëlsson

Blood (2010) 115 (6): 1166–1174.

https://doi.org/10.1182/blood-2009-09-245746

Published: 2010

Includes: Supplemental data

Journal Articles

Different NK cell–activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity

Stephanie M. Wood, Marie Meeths, Samuel C. C. Chiang, Anne Grete Bechensteen, Jaap J. Boelens, Carsten Heilmann, Hisanori Horiuchi, Steen Rosthøj, Olga Rutynowska, Jacek Winiarski, Jennifer L. Stow, Magnus Nordenskjöld, Jan-Inge Henter, Hans-Gustaf Ljunggren, Yenan T. Bryceson

Blood (2009) 114 (19): 4117–4127.

https://doi.org/10.1182/blood-2009-06-225359

Published: 2009

Journal Articles

Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors

Yenan T. Bryceson, Hans-Gustaf Ljunggren, Eric O. Long

Blood (2009) 114 (13): 2657–2666.

https://doi.org/10.1182/blood-2009-01-201632

Published: 2009

Includes: Supplemental data

Journal Articles

KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression

Sandra Andersson, Cyril Fauriat, Jenny-Ann Malmberg, Hans-Gustaf Ljunggren, Karl-Johan Malmberg

Blood (2009) 114 (1): 95–104.

https://doi.org/10.1182/blood-2008-10-184549

Published: 2009

Includes: Supplemental data

Journal Articles

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components

Evren Alici, Tolga Sutlu, Bo Björkstrand, Mari Gilljam, Birgitta Stellan, Hareth Nahi, Hernan Concha Quezada, Gösta Gahrton, Hans-Gustaf Ljunggren, M. Sirac Dilber

Blood (2008) 111 (6): 3155–3162.

https://doi.org/10.1182/blood-2007-09-110312

Published: 2008

Includes: Supplemental data

Journal Articles

Defective cytotoxic lymphocyte degranulation in syntaxin-11–deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients

Yenan T. Bryceson, Eva Rudd, Chengyun Zheng, Josefine Edner, Daoxin Ma, Stephanie M. Wood, Anne Grete Bechensteen, Jaap J. Boelens, Tiraje Celkan, Roula A. Farah, Kjell Hultenby, Jacek Winiarski, Paul A. Roche, Magnus Nordenskjöld, Jan-Inge Henter, Eric O. Long, Hans-Gustaf Ljunggren

Blood (2007) 110 (6): 1906–1915.

https://doi.org/10.1182/blood-2007-02-074468

Published: 2007

Journal Articles

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

Yenan T. Bryceson, Michael E. March, Hans-Gustaf Ljunggren, Eric O. Long

Blood (2006) 107 (1): 159–166.

https://doi.org/10.1182/blood-2005-04-1351

Published: 2006

NARROW

Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination

CD38 Down-Regulation on Ex Vivo Activated and Expanded NK Cells for Cell Therapy Persists after Infusion

Efficient Scale-up and Pre-Clinical Evaluation of NKG2C+ Adaptive NK Cell Expansion for Therapy Against High-Risk AML/MDS

Complete Remission and Signs of Immunoediting Following Haploidentical NK Cell Therapy in Refractory High-Risk MDS and AML Ell Therapy in Refractory High-Risk MDS and AML

Early and Transient Microchimerism Associated with Complete Remission after Adoptively Transferred Haploidentical NK Cells Against High Risk Myelodysplastic Syndrome and Refractory Acute Myeloid Leukemia

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs

Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production

CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells

Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56 dim NK-cell differentiation uncoupled from NK-cell education

NK cells expressing inhibitory KIR for non–self-ligands remain tolerant in HLA-matched sibling stem cell transplantation

Regulation of human NK-cell cytokine and chemokine production by target cell recognition

Education of human natural killer cells by activating killer cell immunoglobulin-like receptors

Different NK cell–activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity

Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors

KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components

Defective cytotoxic lymphocyte degranulation in syntaxin-11–deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only